삼성서울병원

Ko En

Urology Song, Wan M.D

Expertise
Prostate cancer, Robotic surgery, HIFU, Bladder cancer, Kidney cancer,
Treament Schedule 04 月
DATE
MON
01
TUE
02
WEB
03
THU
04
FRI
05
SAT
06
SUN
07
MON
08
TUE
09
WEB
10
THU
11
FRI
12
SAT
13
SUN
14
MON
15
TUE
16
WEB
17
THU
18
FRI
19
SAT
20
SUN
21
MON
22
TUE
23
WEB
24
THU
25
FRI
26
SAT
27
SUN
28
MON
29
TUE
30
AM
PM
Treament Schedule 05 月
DATE
WEB
01
THU
02
FRI
03
SAT
04
SUN
05
MON
06
TUE
07
WEB
08
THU
09
FRI
10
SAT
11
SUN
12
MON
13
TUE
14
WEB
15
THU
16
FRI
17
SAT
18
SUN
19
MON
20
TUE
21
WEB
22
THU
23
FRI
24
SAT
25
SUN
26
MON
27
TUE
28
WEB
29
THU
30
FRI
31
AM
PM

Medical Education

2015~2017 Ph.D. in Medicine Sungkyunkwan University, Korea
2013~2015 Master of Medicine Sungkyunkwan University, Korea
2001~2007 Doctor of Medicine College of Medicine, Korea University, Korea

Post-Graduate Training

Fellowship   2015~2017 Department of Urology, Samsung Medical Center, Korea
Residency   2011~2015 Department of Urology, Samsung Medical Center, Korea
Internship   2007~2008 Korea University Anam Hospital, Korea

Professional Appointments

2022~Present Assiociate Professor Department of Urology, Samsung Medical Center, Korea
2020~2022 Assistant Professor Department of Urology, Samsung Medical Center, Korea
2017~2020 Assistant Professor Department of Urology, Ewha Womans University Mokdong Hospital, Korea

Professional Memberships

2021~Present Member The Korean Prostate Society Academic Committee
2021~Present Member The Korean Prostate Society Focal Therapy Sub-committee
2019~Present Member The Korean Urological Association Academic Committee
2018~Present Member The Korean Urological Oncology Society Academic Committee
2018~Present Member The Korean Urological Oncology Society Bladder Cancer Treatment Guideline Committee
2015~Present Member The Korean Prostate Society
2015~Present Member The Korean Urological Association
2015~Present Member The Korean Urological Oncology Society

Selected Publications

  • PLOS ONE 2021 10.1371/journal.pone.0249709 Biochemical recurrence after radical prostatectomy according to nadir prostate specific antigen value Chung1, JH; Jeong, JY; Lee, JY; Song, W; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Lee, HM; Jeon, SS
    View PubMed
  • BIOLOGY-BASEL 2021 10.3390/biology10040297 Assessment of Agreement between Two Difference Prostate-Specific Antigen Assay Modalities Chung1, JH; Park, M; Cho, H; Song, W; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Lee, HM; Jeon, SS
    View PubMed
  • ONCOTARGETS AND THERAPY 2021 10.2147/OTT.S291327 Prognostic Value of Programmed Death Ligand-1 Expression on Tumor-Infiltrating Immune Cells in Patients Treated with Cisplatin-Based Combination Adjuvant Chemotherapy Following Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Retrospective Cohort Study Lee1, DH; Jeong, JY; Song, W
    View PubMed
  • FRONT ONCOL 2020 10.3389/fonc.2020.568809 Programmed Cell Death-Ligand 1 Expression Status in Urothelial Carcinoma According to Clinical and Pathological Factors A Multi-Institutional Retrospective Study Kim1, HS; Jang, WS; Ham, WS; Jung, SI; Lee, DH; Ku, JH; Ha, HK; Ku, JY; Choi, SY; Chang, IH; Choi, T; Song, W; Jeon, SS; Jeong, BC; Kim, SH; Seo, HK
    View PubMed
  • J KOREAN MED SCI 2020 10.3346/jkms.2020.35.e342 Strategy for Prostate Cancer Patients with Low Prostate Specific Antigen Level (2.5 to 4.0 ng/mL) Chung1, JH; Yu, J; Song, W; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Lee, HM; Jeon, SS
    View PubMed